No Data
Shanghai RAAS Blood Products (002252.SZ): The controlling Shareholder plans to increase its Shareholding by 0.25 billion yuan to -0.5 billion yuan in the company's shares.
On January 8, Gelonghui reported that Shanghai RAAS Blood Products (002252.SZ) announced that it received a notice from its controlling shareholder Haiyingkang (Qingdao) Medical Technology Co., Ltd. (referred to as "Haiyingkang"), informing that Haiyingkang increased its shareholding in the company by a total of 22,933,800 shares through centralized bidding trading on January 7 and 8, 2025, accounting for 0.35% of the company's total share capital, with an increase amount of 155.8467 million yuan (referred to as "first increase"), and plans to increase its shareholding within six months from the date of this announcement (except for legal, regulatory, and Shenzhen Stock Exchange business rules that prohibit further shareholding increase).
Qingdao Haier Biomedical Co., Ltd.'s merger plan for "Blood King" has failed.
A specific plan recognized by all relevant parties could not be formed.
Qingdao Haier Biomedical Nixes Plan to Absorb Shanghai RAAS; Shares Fall 11%
RAAS Blood Products' Chairman Proposes Share Buyback; Shares Down 5%
Qingdao Haier Biomedical Co., Ltd.'s "Elephant Swallowing" failed, stock prices plummeted over 10%, and even the big buyback move proved powerless to save the situation?
What is the reason for this?
Due to a lack of consensus among all parties, Qingdao Haier Biomedical Co., Ltd. has pressed the termination button on the merger with Shanghai RAAS Blood Products | Read the announcement quickly.
① The reason for terminating the reorganization is that the main shareholders of the trading parties and the merging parties failed to formulate a specific plan recognized by all relevant parties; ② Shanghai RAAS Blood Products and Qingdao Haier Biomedical Co., Ltd. will resume trading on January 7 and announce a share buyback simultaneously; ③ According to informed sources, the goal of Haier Group to expand its health sector will not change.
No Data
